Live Breaking News & Updates on Wize Pharma

Stay updated with breaking news from Wize pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

2021 Growth Opportunities in Cell & Gene Therapies, Retinal Diseases, Drug Delivery Platforms, Plant-based Drugs, Cardiac Health, AI-based Devices, Computation Methods, and Cultured Milk


Share this article
Share this article
ResearchAndMarkets.com s offering.
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across retinal diseases, viral and non-viral vector platforms for gene therapies, allogeneic cell therapy, bone repair, gluten antigen-specific drug therapy for Celiac disease, plant-based anti-cancer agents, and food colors. Further, PCR-free whole genome sequencing, oral protein-drug delivery technology for insulin, and cryo transmission electron microscope for viral protein analysis are discussed.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. ....

United Kingdom , Wize Pharma , Laura Wood , Office Hours Call , Health Wellness , Rensselaer Polytechnic Institute , Visus Therapeutics Inc , Oramed Pharmaceuticals , Novosteo Inc , Exonate Ltd , Health Wellness Technology Opportunity Engine , E St Office Hours Call , Innovations In Life Sciences , Gene Therapies , Retinal Diseases , Drug Delivery Platforms , Plant Based Drugs , Cardiac Health , Computation Methods , Life Science , Wellness Technology Opportunity Engine , Topics Covered , Life Sciences , Polytechnic Institute , Fisher Scientific , Dose Therapeutics ,

Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers


Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031
In-depth Analysis of Top 50 Ophthalmic Drug Manufacturers: Capabilities, Results, Competition and Sales Potentials Visiongain has published a new Pharma Leader Series report on Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031.
May 05, 2021 10:45 ET
| Source:
ReportLinker
ReportLinker
Lyon, FRANCE
New York, May 05, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031 - https://www.reportlinker.com/p06067745/?utm source=GNW
The global ophthalmic drugs manufacturers market is estimated to be valued at US$xx billion in 2021 and is projected to reach at a market value of US$xx billion by 2031. ....

New York , United States , Gensight Biologics , Staar Surgicals , Ophthalix Wize Pharma , Carl Zeiss Meditec , Alimera Sciences , Innovexia Life Sciences , Santen Pharmaceuticals , Glaukos Corporation , Abbvie Inc , Regeneron Pharmaceuticals Inc , Rohto Pharmaceutical Co Ltd , Roche Holding Ag , Johnson Vision Company , Teva Pharmaceuticals , Ampio Pharmaceuticals , Essilor International , Eyegate Pharmaceuticals , Edwards Lifesciences Corp , Kodiak Sciences Inc , Ellex Medical Lasers Ltd , Bora Pharmaceuticals Co Ltd , Kubota Pharmaceutical Holdings Co Ltd , Merck Co , Phio Pharmaceuticals Corp ,